Broxyquinoline

CHEMBL223448 Phase 4 Одобрено Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
303.0 g/mol
LogP
3.2
Phase
4

An antimicrobial compound with activity against bacteria, fungi, and protozoa, used historically as an intestinal antiseptic for traveler's diarrhea and intestinal infections. It is a halogenated hydroxyquinoline derivative. Its use has declined due to safety concerns seen with related compounds in the same chemical class.

Молекулярная масса

302,9500 g/mol

LogP

3,20

TPSA

33,10 Ų

Правило пяти Липинского

Соответствует

Механизм действия

Disrupts microbial cell membranes and denatures proteins on contact, producing rapid broad-spectrum antimicrobial activity on skin and wound surfaces.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Механизм

Disrupts microbial cell membranes and denatures proteins on contact, producing rapid broad-spectrum antimicrobial activity on skin and wound surfaces.

2D Структура

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Oc1c(Br)cc(Br)c2cccnc12

InChI

InChI=1S/C9H5Br2NO/c10-6-4-7(11)9(13)8-5(6)2-1-3-12-8/h1-4,13H

Molecular Formula

C9H5Br2NO

HBD / HBA

1 / 2

Вращаемые Связи

0

Тяжёлые Атомы

13

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Часто задаваемые вопросы

An antimicrobial compound with activity against bacteria, fungi, and protozoa, used historically as an intestinal antiseptic for traveler's diarrhea and intestinal infections. It is a halogenated hydroxyquinoline derivative. Its use has declined due to safety concerns seen with related compounds in the same chemical class.

Disrupts microbial cell membranes and denatures proteins on contact, producing rapid broad-spectrum antimicrobial activity on skin and wound surfaces.

Yes, Broxyquinoline is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL223448. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 2453. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Медицинский отказ от ответственности

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.